The Validity of the Quick Renal MRI in Pediatric Kidney Disease
Launched by UNIVERSITY OF WISCONSIN, MADISON · May 20, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new imaging method called the quick renal MRI, which aims to provide a faster, safer way to look at children's kidneys without the need for injections, sedation, or radiation. The goal is to see if this new MRI technique is as accurate as the traditional DMSA scan, which is currently used to check for kidney infections and scarring. If the quick renal MRI proves to be effective, it could make testing easier and less stressful for children with kidney issues.
Children from birth to 21 years old who are being treated for kidney infections or have had multiple urinary tract infections may be eligible to participate. Depending on which part of the study they are in, participants can expect to be involved for anywhere from one week to six months. It's important to know that some children may not qualify if they show certain conditions in their urine tests or are not comfortable with the MRI procedure. Overall, this trial could lead to better ways to evaluate kidney health in children.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Aim 1:
- • Patient is admitted to American Family Children's Hospital for a febrile UTI, suspected pyelonephritis, or diagnosed pyelonephritis
- • Undergoing clinical DMSA scan
- * Aim 2:
- • Undergoing DMSA scans as a part of their routine clinical care
- • History of more than one UTI in the past year
- Exclusion Criteria:
- * Aim 1:
- • No evidence of pyuria on their urine analysis
- • Negative urine culture
- • Not comfortable with having a Quick MRI performed
- * Both aims:
- • Contraindications to MRI
About University Of Wisconsin, Madison
The University of Wisconsin-Madison is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive resources, including cutting-edge facilities and a diverse pool of expert researchers, to conduct rigorous studies that address critical health challenges. The institution's focus on translating research findings into practical applications fosters the development of new treatments and interventions, ultimately contributing to improved patient outcomes and public health initiatives. As a sponsor of clinical trials, the University of Wisconsin-Madison is dedicated to upholding the highest ethical standards and ensuring participant safety throughout the research process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madison, Wisconsin, United States
Patients applied
Trial Officials
Shannon Cannon, MD
Principal Investigator
University of Wisconsin, Madison
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials